Hers vs LTTL: Brand-name Wegovy vs Compounded GLP-1 Options
Hers vs LTTL splits on two clear axes: Hers emphasizes FDA-approved brand-name Wegovy® (starting at $149/mo) and a required membership, while LTTL offers compounded GLP-1 medications with up to $140 off your first month. Early verdict: choose Hers for FDA-approved, brand-name semaglutide and a personalized care team; choose LTTL if you prioritize compounded formulations and an applied first-month code.
How Hers and LTTL differ on medication type and regulatory status
Hers offers FDA-approved Wegovy® (brand-name semaglutide) and states it does not offer compounded medications. LTTL provides compounded GLP-1 medications prepared by U.S.A. licensed pharmacies and notes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. This is a primary distinction: Hers sells name-brand, FDA-approved products; LTTL emphasizes compounded formulations.
Pricing structure and up-front costs compared
Hers lists Wegovy® from $149/mo and injectable options from $199/mo, and it states an active Hers Weight Loss Membership is required ($39 first month, auto-renews at $149/month thereafter) with medication billed separately. LTTL lists a starting price of $140 and marketing content saying up to $140 off your first month with a code auto-applied and claims such as same price every dose and example price points like $249 and $129 (4 doses/month). The providers present different billing models: Hers requires a membership for medication access; LTTL highlights a promotional first-month credit.
CTA and enrollment notes
Both providers say treatment is available only when a licensed clinician determines it is medically appropriate. Hers notes medications are not available without an active membership and that prescription is not guaranteed. LTTL materials caution pricing, eligibility, pharmacy, state coverage and renewal terms may change.
See LTTL compounded GLP-1 offers
Care model: personalized team vs compounded fulfillment
Hers advertises a personalized care team with ongoing dose check-ins as part of its offering. LTTL emphasizes pharmacy preparation and lab verification: compounded medications are prepared in state-licensed pharmacies, independently verified in FDA-registered labs, and confirmed every 3–6 months to stay within ± 10% of the target strength. Hers focuses on provider-directed dose check-ins; LTTL emphasizes pharmacy quality-control processes for compounded products.
Availability notes, eligibility and state coverage
Hers states not available in all 50 states, prescription required, and that Ozempic® and Mounjaro® are FDA-approved for type 2 diabetes and available only to patients who meet clinical eligibility criteria determined by a licensed provider. LTTL cautions pricing, eligibility, pharmacy, state coverage and renewal terms may change. Both require clinician review as part of access.
Comparison table: Hers vs LTTL at a glance
| Criteria | Hers | LTTL |
|---|---|---|
| Medication type | FDA-approved Wegovy® (brand-name semaglutide); no compounded medications | Compounded GLP-1 medications prepared by U.S.A. licensed pharmacies |
| Starting price | From $149/mo (Wegovy®); injectables from $199/mo | Starting price listed $140; up to $140 off first month (code auto-applied) |
| Membership/fees | Active Hers Weight Loss Membership required ($39 first month, auto-renews at $149/mo) | Promotional first-month credit; other billing terms not fully verified |
| Regulatory note | Brand-name FDA-approved medication; no compounded products | Compounded meds not FDA-approved and not reviewed by FDA |
| Quality verification | Personalized care team with ongoing dose check-ins | Prepared in state-licensed pharmacies; independently verified in FDA-registered labs; confirmed every 3–6 months |
Distinctive differences summarized
Three to five most distinctive supported differences: medication regulatory status (FDA-approved Wegovy® at Hers vs compounded GLP-1 at LTTL), pricing model (Hers membership plus medication charges vs LTTL promotional first-month credit), care model (personalized care team dose check-ins at Hers vs pharmacy lab verification at LTTL), state availability and clinician eligibility requirements for both, and explicit regulatory warnings that compounded medications are not FDA-reviewed.
Browse LTTL pharmacy and verification details
Bottom line and who should choose which
Hers vs LTTL comes down to whether you want an FDA-approved, brand-name GLP-1 with a structured membership and care team (Hers) or a compounded GLP-1 product prepared by licensed pharmacies with an applied first-month credit and different pricing examples (LTTL). Both require clinician review and note prescription is not guaranteed.
Choose Hers if…
You prioritize FDA-approved, brand-name Wegovy®, ongoing dose check-ins with a personalized care team, and accept a required membership to access medication.
Choose LTTL if…
You prefer compounded GLP-1 formulations prepared by U.S.A. licensed pharmacies, want an applied first-month credit up to $140, and accept that compounded medications are not FDA-approved.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →More comparisons
